Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2022-08-17 00:00:00 ET · period of report 2022-08-15 · accession 0001209191-22-046461 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-17 | 2022-08-15 | RXRX | Gibson Christopher | CEO, Dir | F - Tax | $12.96 | -5,751 | 536.1K | -1% | -$74.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-08-15 | F | D | 5,751 | $12.96 | 536,078 | D | — | — |